Addiction
158
22
30
82
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
20 trials with published results (13%)
Research Maturity
82 completed trials (52% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.1%
8 terminated out of 158 trials
91.1%
+4.6% vs benchmark
3%
4 trials in Phase 3/4
24%
20 of 82 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 82 completed trials
Clinical Trials (158)
Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)
Tirzepatide Impact Assessment Study
EFFECTIVENESS OF SOLUTION-FOCUSED APPROACH-BASED PSYCHOEDUCATION IN INDIVIDUALS DIAGNOSED WITH SUBSTANCE USE DISORDER: A RANDOMIZED CONTROLLED TRIAL
Role of Craving in the Transition Across Level of Addiction Severity: A Longitudinal Study.
Semaglutide Therapy for Alcohol Reduction (STAR)
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Behavioral and Functional Task Development, Implementation, and Testing
Comparative Evaluation of Nicotine Analogs
Mobile Restriction on Dopamine Transporter
Neuroimaging of Adolescent Cannabis Use Treatment
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
Linking fMRI to Mobile Technologies in Addiction Research: Pathophysiology of Executive Deficits, Craving and Substance Use
Support Towards Addiction Recovery for Individuals With Criminal Legal System Involvement: The STAR Project
Pain and Upper Extremity Function in Smartphone and Digital Game Addiction
Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.
NLP Analysis of Weekly Narratives for Dynamic Clinical Assessment in SUD
Cross-sectional Functional Stratification Based on Psychometric Profiling and Machine Learning in Patients With Substance Use Disorders (SUD)
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use Disorders
Group Activities to Support Addiction Recovery